Waghray Meghna, Yalamanchili Malica, Dziubinski Michele, Zeinali Mina, Erkkinen Marguerite, Yang Huibin, Schradle Kara A, Urs Sumithra, Pasca Di Magliano Marina, Welling Theodore H, Palmbos Phillip L, Abel Ethan V, Sahai Vaibhav, Nagrath Sunitha, Wang Lidong, Simeone Diane M
Department of Surgery, University of Michigan, Ann Arbor, Michigan. Pancreatic Cancer Center, University of Michigan, Ann Arbor, Michigan. Translational Oncology Program, University of Michigan, Ann Arbor, Michigan.
Department of Surgery, University of Michigan, Ann Arbor, Michigan. Translational Oncology Program, University of Michigan, Ann Arbor, Michigan.
Cancer Discov. 2016 Aug;6(8):886-99. doi: 10.1158/2159-8290.CD-15-0947. Epub 2016 May 16.
UNLABELLED: Pancreatic ductal adenocarcinoma (PDA) is characterized by a dense stroma consisting of a prevalence of activated fibroblasts whose functional contributions to pancreatic tumorigenesis remain incompletely understood. In this study, we provide the first identification and characterization of mesenchymal stem cells (MSC) within the human PDA microenvironment, highlighting the heterogeneity of the fibroblast population. Primary patient PDA samples and low-passage human pancreatic cancer-associated fibroblast cultures were found to contain a unique population of cancer-associated MSCs (CA-MSC). CA-MSCs markedly enhanced the growth, invasion, and metastatic potential of PDA cancer cells. CA-MSCs secreted the cytokine GM-CSF that was required for tumor cell proliferation, invasion, and transendothelial migration. Depletion of GM-CSF in CA-MSCs inhibited the ability of these cells to promote tumor cell growth and metastasis. Together, these data identify a population of MSCs within the tumor microenvironment that possesses a unique ability, through GM-CSF signaling, to promote PDA survival and metastasis. SIGNIFICANCE: The role of stroma in pancreatic cancer is controversial. Here, we provide the first characterization of MSCs within the human PDA microenvironment and demonstrate that CA-MSCs promote tumorigenesis through the production of GM-CSF. These data identify a novel cytokine pathway that mediates mesenchymal-epithelial cross-talk and is amenable to therapeutic intervention. Cancer Discov; 6(8); 886-99. ©2016 AACR.This article is highlighted in the In This Issue feature, p. 803.
Cancer Discov. 2016-8
J Cancer Res Clin Oncol. 2019-2-25
Proc Natl Acad Sci U S A. 2018-4-3
Exp Hematol Oncol. 2025-7-17
Cancer Biol Med. 2025-7-7
Nat Rev Gastroenterol Hepatol. 2025-4-14
Front Bioeng Biotechnol. 2024-10-21
Cell Biol Toxicol. 2024-9-16
J Gastrointest Cancer. 2024-12
Cancer Cell. 2014-5-22
Cancer Med. 2014-8
Biochem Biophys Res Commun. 2012-4-9